Steven Cohen Relay Therapeutics, Inc. Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 10,827,067 shares of RLAY stock, worth $30.2 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
10,827,067
Previous 1,592,753
579.77%
Holding current value
$30.2 Million
Previous $6.56 Million
332.28%
% of portfolio
0.07%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding RLAY
# of Institutions
214Shares Held
157MCall Options Held
153KPut Options Held
49.2K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$77.9 Million0.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.1MShares$33.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$29.4 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.1MShares$25.4 Million2.79% of portfolio
-
Tang Capital Management LLC San Diego, CA8.07MShares$22.5 Million1.37% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $335M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...